Overview

An Open Label Study to Examine the Effect of Coated Nifedipine Suppositories on Anal Pressure in Healthy Subjects

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This is an open label, dose-finding study. Approximately 8 healthy subjects will be participating in this study. Within one week after the screening visit, subjects who meet all inclusion criteria and none of the exclusion criteria will enter a one day treatment period. During this period, 4 anal manometric studies will take place. Study medication (Coated Nifedipine suppositories at various doses) will be administered at pre-determined intervals. During the study, blood samples will be obtained for plasma Nifedipine analysis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
RDD Pharma Ltd
Treatments:
Nifedipine